Pulmonary Ground-Glass Opacity (GGO) Lesions–Large Size and a History of Lung Cancer are Risk Factors for Growth

Objective: Ground-glass opacity (GGO) of the lung is being frequently detected by thin section computed tomography scan. However, the long term management of detected GGO is still unclear. To establish follow-up plans, we performed the clinical and radiological review to identify the factors that are closely associated with GGO growth. Methods: We retrospectively analyzed computed tomography images of 125 GGOs that were stable for 3 months between 1999 and 2006 at the Cancer Institute Hospital, Tokyo. To identify factors that affect the roentgenological growth, the time to GGO growth curve by Kaplan-Meyer method was evaluated in terms of gender, age, smoking, initial size, existence of a solid part, GGO density, location, multiplicity, and lung cancer history by univariate and multivariate analyses. Results: The median observation period was 1048 days (177–3269) and 26 of 125 GGOs (21%) grew. The estimated growth population for 5 years was 30%. The growth was more frequently seen in the elderly (p = 0.017), in part-solid GGO (p < 0.01) and in GGO of larger than 10 mm (p < 0.01, logrank test). By multivariate analysis, initial size (p < 0.01, Cox’s model) and history of lung cancer (p = 0.017, logistic model) were independent factors that were significantly associated with GGO growth. Fifty GGOs that were 10 mm or smaller and without a lung cancer history did not grow within 3.5 years. Conclusions: After initial management and 3 month follow-up, larger size (more than 10 mm) and a history of lung cancer are risk factors for GGO growth, and therefore should be considered when making a follow-up plan.

[1]  B. Corrin,et al.  Second primary lung cancer: importance of long term follow up. , 1989, Thorax.

[2]  Feng Li,et al.  Mass screening for lung cancer with mobile spiral computed tomography scanner , 1998, The Lancet.

[3]  K. Ohshima,et al.  ©1999 Cancer Research Campaign Article no. bjoc.1998.0247 Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation , 2022 .

[4]  T. Oyama,et al.  [Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?]. , 2002, Kyobu geka. The Japanese journal of thoracic surgery.

[5]  J. Austin,et al.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. , 1996, Radiology.

[6]  Kenji Eguchi,et al.  Focal ground-glass opacity detected by low-dose helical CT. , 2002, Chest.

[7]  Y. Kawakami,et al.  [The outline of the general rule for clinical and pathological record of lung cancer]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[8]  Anthony P. Reeves,et al.  CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. , 2007, Radiology.

[9]  Y. Inayama,et al.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. , 1995, The American journal of pathology.

[10]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[11]  C. Henschke,et al.  Managing the small pulmonary nodule discovered by CT. , 2004, Chest.

[12]  T. Fabian Multiple primary lung cancers. , 2018, Journal of thoracic disease.

[13]  M. Okada,et al.  Operative approach for multiple primary lung carcinomas. , 1998, The Journal of thoracic and cardiovascular surgery.

[14]  N. Müller,et al.  Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. , 1991, Radiology.

[15]  E J Stern,et al.  Ground-glass opacity at CT: the ABCs. , 1997, AJR. American journal of roentgenology.

[16]  S. Sone,et al.  CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. , 2003, AJR. American journal of roentgenology.

[17]  S Sone,et al.  Growth rate of small lung cancers detected on mass CT screening. , 2000, The British journal of radiology.

[18]  R. Okita,et al.  Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. , 2005, The Annals of thoracic surgery.

[19]  J. Rutherford,et al.  Second primary lung cancer. , 1995, The Annals of thoracic surgery.

[20]  H Nakata,et al.  Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. , 2000, AJR. American journal of roentgenology.

[21]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[22]  Ken Kodama,et al.  Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. , 2002, The Annals of thoracic surgery.

[23]  M. Burt,et al.  Multiple primary lung carcinomas: prognosis and treatment. , 1991, The Annals of thoracic surgery.

[24]  Ryutaro Kakinuma,et al.  Localized Pure Ground-Glass Opacity on High-Resolution CT: Histologic Characteristics , 2002, Journal of computer assisted tomography.

[25]  H. Munechika,et al.  Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. , 1994, Radiology.

[26]  K S Lee,et al.  Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. , 1996, Radiology.

[27]  O. Miettinen,et al.  CT screening for lung cancer: significance of diagnoses in its baseline cycle. , 2006, Clinical imaging.